πŸ‡ΊπŸ‡Έ FDA
Patent

US 11820824

Antibodies to TIGIT

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11820824 (Antibodies to TIGIT) held by Arcus Biosciences, Inc. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P35/00